Cleared Traditional

K844914 - ABBOTT PREGNA-PLUS HUMAN CHORIONIC GONADOTROPIN EN (FDA 510(k) Clearance)

Feb 1985
Decision
56d
Days
Class 2
Risk

K844914 is an FDA 510(k) clearance for the ABBOTT PREGNA-PLUS HUMAN CHORIONIC GONADOTROPIN EN. This device is classified as a Agglutination Method, Human Chorionic Gonadotropin (Class II - Special Controls, product code JHJ).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on February 12, 1985, 56 days after receiving the submission on December 18, 1984.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1155.

Submission Details

510(k) Number K844914 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 18, 1984
Decision Date February 12, 1985
Days to Decision 56 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary

Device Classification

Product Code JHJ — Agglutination Method, Human Chorionic Gonadotropin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1155